Matteo Lazzeroni

24PUBLICATIONS
97CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Models of care and place of birthRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 31, 2026
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

|Oct 30, 2025
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Irene Maria Briata, Stefano Spinaci, Parijatham S Thomas

|May 14, 2025
Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches.

Monica Marabelli, Mariarosaria Calvello, Elena Marino

|Apr 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.

Harriet Johansson, Debora Macis, Martino Oliva

|Jan 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.

Eliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga

|Sep 03, 2024
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.

Aliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella

Pageof 4

Frequent Collaborators

13 joint publications

Bernardo Bonanni

11 joint publications

Davide Serrano

10 joint publications

Aliana Guerrieri-Gonzaga

8 joint publications

Sara Gandini